SILO PHARMA, INC. Investments, Fair Value Disclosure
SILO PHARMA, INC. (SILO) had Investments, Fair Value Disclosure of $149.97 thousand as of 2019-06-30, per its 10-Q filed 2019-08-13.
Discontinued › Notes › Fair Value Disclosures › Financial Instruments, Financial Assets, Balance Sheet Groupings
us-gaap:InvestmentsFairValueDisclosure · last filed 2020-03-20
- 2019-06-30: Investments, Fair Value Disclosure $149.97K.
- 2019-03-31: Investments, Fair Value Disclosure $264.02K.
- 2018-12-31: Investments, Fair Value Disclosure $215.53K.
| Period end | Investments, Fair Value Disclosure |
|---|---|
| 2019-06-30 | $149.97K 10-Q · filed 2019-08-13 |
| 2019-03-31 | $264.02K 10-Q · filed 2019-05-14 |
| 2018-12-31 | $215.53K 10-K · filed 2020-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |